These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 8333844

  • 21. A folding inhibitor of the HIV-1 protease.
    Broglia RA, Provasi D, Vasile F, Ottolina G, Longhi R, Tiana G.
    Proteins; 2006 Mar 01; 62(4):928-33. PubMed ID: 16385559
    [Abstract] [Full Text] [Related]

  • 22. The structural stability of the HIV-1 protease.
    Todd MJ, Semo N, Freire E.
    J Mol Biol; 1998 Oct 23; 283(2):475-88. PubMed ID: 9769219
    [Abstract] [Full Text] [Related]

  • 23. Systematic mutational analysis of the active-site threonine of HIV-1 proteinase: rethinking the "fireman's grip" hypothesis.
    Strisovsky K, Tessmer U, Langner J, Konvalinka J, Kräusslich HG.
    Protein Sci; 2000 Sep 23; 9(9):1631-41. PubMed ID: 11045610
    [Abstract] [Full Text] [Related]

  • 24. The pH-dependent subunit dissociation and catalytic activity of bovine dopamine beta-hydroxylase.
    Saxena A, Hensley P, Osborne JC, Fleming PJ.
    J Biol Chem; 1985 Mar 25; 260(6):3386-92. PubMed ID: 3972830
    [Abstract] [Full Text] [Related]

  • 25. Mechanical effects on the kinetics of the HIV proteinase deactivation.
    Kuzmic P, Peranteau AG, García-Echeverría G, Rich DH.
    Biochem Biophys Res Commun; 1996 Apr 16; 221(2):313-7. PubMed ID: 8619852
    [Abstract] [Full Text] [Related]

  • 26. Activity of linked HIV-1 proteinase dimers containing mutations in the active site region.
    Bagossi P, Cheng YS, Oroszlan S, Tözsér J.
    Protein Eng; 1996 Nov 16; 9(11):997-1003. PubMed ID: 8961352
    [Abstract] [Full Text] [Related]

  • 27. HIV-1 protease substrate-groove: Role in substrate recognition and inhibitor resistance.
    Laco GS.
    Biochimie; 2015 Nov 16; 118():90-103. PubMed ID: 26300060
    [Abstract] [Full Text] [Related]

  • 28. Analysis of the pH-dependencies of the association and dissociation kinetics of HIV-1 protease inhibitors.
    Gossas T, Danielson UH.
    J Mol Recognit; 2003 Nov 16; 16(4):203-12. PubMed ID: 12898670
    [Abstract] [Full Text] [Related]

  • 29. The inhibition of HIV-1 protease by interface peptides.
    Schramm HJ, Billich A, Jaeger E, Rücknagel KP, Arnold G, Schramm W.
    Biochem Biophys Res Commun; 1993 Jul 30; 194(2):595-600. PubMed ID: 8343146
    [Abstract] [Full Text] [Related]

  • 30. Active human cytomegalovirus protease is a dimer.
    Darke PL, Cole JL, Waxman L, Hall DL, Sardana MK, Kuo LC.
    J Biol Chem; 1996 Mar 29; 271(13):7445-9. PubMed ID: 8631772
    [Abstract] [Full Text] [Related]

  • 31. [Specific ligand induced dimerization of allosteric enzymes].
    Kurganov BI.
    Mol Biol (Mosk); 1982 Mar 29; 16(2):424-33. PubMed ID: 7073865
    [Abstract] [Full Text] [Related]

  • 32. Total chemical synthesis of a D-enzyme: the enantiomers of HIV-1 protease show reciprocal chiral substrate specificity [corrected].
    Milton RC, Milton SC, Kent SB.
    Science; 1992 Jun 05; 256(5062):1445-8. PubMed ID: 1604320
    [Abstract] [Full Text] [Related]

  • 33. Comparison of the specificity of homo- and heterodimeric linked HIV-1 and HIV-2 proteinase dimers.
    Bagossi P, Cheng YS, Oroszlan S, Tözsér J.
    Protein Eng; 1998 Jun 05; 11(6):439-45. PubMed ID: 9725622
    [Abstract] [Full Text] [Related]

  • 34. Kinetics and mechanism of autoprocessing of human immunodeficiency virus type 1 protease from an analog of the Gag-Pol polyprotein.
    Louis JM, Nashed NT, Parris KD, Kimmel AR, Jerina DM.
    Proc Natl Acad Sci U S A; 1994 Aug 16; 91(17):7970-4. PubMed ID: 8058744
    [Abstract] [Full Text] [Related]

  • 35. An engineered retroviral proteinase from myeloblastosis associated virus acquires pH dependence and substrate specificity of the HIV-1 proteinase.
    Konvalinka J, Horejsí M, Andreánsky M, Novek P, Pichová I, Bláha I, Fábry M, Sedlácek J, Foundling S, Strop P.
    EMBO J; 1992 Mar 16; 11(3):1141-4. PubMed ID: 1547777
    [Abstract] [Full Text] [Related]

  • 36. Functional characterization of the protease of human endogenous retrovirus, K10: can it complement HIV-1 protease?
    Towler EM, Gulnik SV, Bhat TN, Xie D, Gustschina E, Sumpter TR, Robertson N, Jones C, Sauter M, Mueller-Lantzsch N, Debouck C, Erickson JW.
    Biochemistry; 1998 Dec 08; 37(49):17137-44. PubMed ID: 9860826
    [Abstract] [Full Text] [Related]

  • 37. Solution NMR evidence that the HIV-1 protease catalytic aspartyl groups have different ionization states in the complex formed with the asymmetric drug KNI-272.
    Wang YX, Freedberg DI, Yamazaki T, Wingfield PT, Stahl SJ, Kaufman JD, Kiso Y, Torchia DA.
    Biochemistry; 1996 Aug 06; 35(31):9945-50. PubMed ID: 8756455
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.